Institut Cancerologie De L'ouest
Clinical trials sponsored by Institut Cancerologie De L'ouest, explained in plain language.
-
Targeted bone marrow blast for myeloma relapse shows early promise but trial halted
Disease control TerminatedThis early-phase study tested a combination of high-dose melphalan chemotherapy and escalating doses of total bone marrow irradiation, followed by a stem cell rescue, in 13 patients with multiple myeloma that had returned after first treatment. The goal was to find the safest hig…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Relaxation method studied to ease anxiety in brain tumor patients
Symptom relief TerminatedThis study tested whether adding sophrology—a relaxation technique using hypnosis, meditation, and breathing exercises—to standard speech therapy could help reduce anxiety and improve quality of life in people with aggressive brain tumors (glial tumors). The trial planned to enro…
Phase: NA • Sponsor: Institut Cancerologie de l'Ouest • Aim: Symptom relief
Last updated Jun 23, 2026 12:09 UTC